Risk Factors and Mortality Among Women With Interval Breast Cancer vs Screen-Detected Breast Cancer

Author:

Song Huiyeon1,Tran Thi Xuan Mai1,Kim Soyeoun2,Park Boyoung13

Affiliation:

1. Department of Preventive Medicine, Hanyang University College of Medicine, Seoul, Republic of Korea

2. Biomedical Research Institute, Seoul National University Hospital, Seoul, Republic of Korea

3. Hanyang Institute of Bioscience and Biotechnology, Hanyang University, Seoul, Republic of Korea

Abstract

ImportanceThe risk factors for interval breast cancer (IBC) compared with those for screen-detected breast cancer (SBC) and their association with mortality outcomes have not yet been evaluated among Korean women.ObjectiveTo evaluate risk factors associated with IBC and survival among Korean women with IBC compared with those with SBC.Design, Setting, and ParticipantsThis retrospective cohort study used data from the Korean National Health Insurance Service Database. Women who participated in a national mammographic breast cancer screening program between January 1, 2009, and December 31, 2012, were included. Mortality outcomes were calculated from the date of breast cancer diagnosis to the date of death or December 31, 2020. Data were analyzed from March 1 to June 30, 2023.ExposureBreast cancer diagnosed within 6 to 24 months after a negative screening result (ie, IBC) or within 6 months after a positive screening result (ie, SBC).Main Outcomes and MeasuresRisk factors and survival rates for IBC and SBC.ResultsThis study included 8702 women with IBC (mean [SD] age, 53.3 [8.6] years) and 9492 women with SBC (mean [SD] age, 54.1 [9.0] years). Compared with SBC, the probability of IBC decreased as mammographic density increased. Lower body mass index, menopausal status, hormone replacement therapy (HRT) use, and lack of family history of breast cancer were associated with a higher likelihood of IBC. When stratified by detection time, younger age at breast cancer diagnosis and family history of breast cancer were associated with an increased likelihood of IBC diagnosed at 6 to 12 months but a decreased likelihood of IBC diagnosed at 12 to 24 months. Overall mortality of IBC was comparable with SBC, but total mortality and cancer-related mortality of IBC diagnosed between 6 and 12 months was higher than that of SBC.Conclusions and RelevanceThe findings of this cohort study suggest that breast density, obesity, and HRT use were associated with IBC compared with SBC. These findings also suggest that higher supplemental breast ultrasound use among Korean women, especially those with dense breasts, could be attributed to a lower incidence of IBC among women with dense breasts compared with women with SBC, due to greater detection. Finally, overall mortality of IBC was comparable with that of SBC.

Publisher

American Medical Association (AMA)

Reference42 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.;Sung;CA Cancer J Clin,2021

2. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2019.;Kang;Cancer Res Treat,2022

3. Global guidelines for breast cancer screening: a systematic review.;Ren;Breast,2022

4. Overview of the National Cancer Screening Programme and the cancer screening status in Korea.;Kim;Asian Pac J Cancer Prev,2011

5. Mammographic density and survival in interval breast cancers.;Eriksson;Breast Cancer Res,2013

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3